accountIn his various roles as a computer programmer, an emergency-medicine physician, and the director of Microsoft (MSFT)...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
3,356 news
and
4,658 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
A "2" way approach to business The Cancer Health forecasts are very promising and are expected to grow at a...
Nov. 4 (Bloomberg) -- Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack...
Nov. 2 (Bloomberg) -- Takeda Pharmaceutical Co., maker of the world’s best-selling diabetes drug, agreed to pay as much...
From this week's Hedge Fund Solutions Catalyst Equity Research Report, we are highlighting the Biotechnology Value...
New York, NY (AHN) – Genomic researcher J. Craig Venter has been awarded The Economist magazine’s Innovation Award for...
The drug giant suffers a setback in its effort to boost its oncology pipeline.
Tumor-targeted REXIN-G Quells Metastatic Osteosarcoma, Prostate Cancer, and Pancreas Cancer as Stand-alone Therapy.
Talecris Biotherapeutics (TLCR) plans to go public this week. The biotech company is a maker of plasma-derived protein...
A new way of attacking the painful skin disease had received the green light from the FDA.
When VCs consider a biotech investment, they usually factor the direct costs of the studies they’re being asked to fund...
When Arena Pharmaceuticals (Nasdaq: ARNA) released positive Phase III data on its obesity drug, Lorcaserin, many people...
Pascal Soriot, the man charged with integrating Roche Holding AG (SWX:ROG) and Genentech Inc. -- alongside former...
Wall Street pored over new trial results for Amgen's anemia drug Aranesp on Aug. 26
A recent report issued by Scientific American, "Scientific American Worldview: A Global Biotechnology...
Drugmakers may push for an overhaul of the U.S. health care system by spending $100 million on ads starting as early as...
They say that nobody should start a company to make money. Here’s proof: for all the buzz about biotech, in 40 years...
Should a branded biotech get 5 years or 12 years of protection from generic competition?
According to this article in outsourcing-pharma.com Pfizer has teamed up with Private Access Team to boost trial...
Human Genome Sciences Inc shares rose nearly 12 percent on Tuesday on rumors that Glaxo may buy the long-struggling...
www.BiotechIndustryStocks.com, a global investor website for the biotechnology sector within Investorideas.
I have remarkable news for you. It ranks, in fact, among the great humanitarian breakthroughs of our age. BioTime, Inc.
Investors are eager for news on denosumab, which the FDA will be discussing soon.
Companies are developing knee patches: small, off-the-shelf plugs engineered to the composition of human bone and...
Top Sources: Business of Biotechnology
- contrarianprofits.com
- Forbes.com
- Health Beat
- industry.bnet.com
- thestreet.com
- news.bbc.co.uk
- investorideas.com
- Reuters
- frontendofinnovation.blogspot.com
- BusinessWeek
